the space. >> karen. >> if foot locker trades down on the nike news, buy it below 57. >> you know what traded light, gold. buy gdx. >> i'm melissa lee. thanks f my mission is simple. to make you money. i'm here to level the playing field for all investors. there's always a bull market somewhere and i promise to help you find it. "mad money" starts now. hey, i'm cramer! welcome to "mad money," welcome to cramerica. other people want to make friends. well, i'm trying to have more days like today. my job is not just to entertain but teach and put it in context. call me. or tweet me. @jimcramer. when you get a massive move like this one, a genuine -- with the

dow up, s&p 500 up and nasdaq soaring, it is remarkable to see the makeup. it is almost as if there's a recipe, a sure fire way to bake a bull cake, so to speak. and what exactly are the ingredients? first, the most important ingredient for turbo charged market is growth without inflation. this has always been the holy grail of every single rally i've ever seen since i started to invest in 1979. at yesterday's meeting, janet yell ensaid we have that combination. the fact it is not producing wayne gains or housing market means it may not be helping regular people but does it work wonders for the stock market, always does, always well. stocks as an asset class perform best when this rare inflation

without growth or success. what i call an exquisite moment. two. we know you should never fight the fed. this is an old adage i heard on wall street week. he had done empirical work showing when the fed lowered rates, keeping them so low they don't compete with the stock market, you tend to make a ton of dough owning stocks. well, this fed is so on the side of bulls, people are blasting yellen for being dishonest. if she would sell the bonds, she could eliminate the criticism. but she won't do that. still, she's darn accommodative. that means you're fighting the fed and tape if you're betting against stocks. just recognize this is positive for the market. three. you don't want the rest of the government involved in the front page of the business section. these days, both parties are

showing they're consistently willing to stymy the growth of business. washington is taxing the heck out of our economy. the only thing president obama is on the front page for is opening the u.s. market to cuban businesses. meanwhile, jeb bush throws his hat in the ring for 2016, a moderate candidate who can get the republican nomination. congress seems to be on hold, passed a bill budget last weekend that was a big deal. it blunted the mischief of ted cruz as disturbing with the bulls as warren is from the left. you may like these politicians, but this is "mad money," not mad politics. they're toxic for higher stock prices. fourth ingredient for an epic rally. yeah, you bet. you need a cessation of geopolitical worries. don't have that.

that vladimir putin is against western adventurism, i am regarding as a positive. he put out olive branches, that was bizarre. may or may not be genuine. if the issue of ukraine goes away, europe will be in better position to rebound from its slump. 70 million people live there and take 25% of china's exports, this really matters. putin remains the biggest men as in the world now. and it would be terrific to see him get off the front pages, if not out of office. okay. the fifth ingredient to bake an unbelievably important bull cake. well, whenever whatever commodity or currency, something hurts the bull case, suddenly slows down so people can catch their breath. that's what's happening. oil broke down again. i like a little salt. i don't expect it to stay in the 50s. there's too much supply, not enough demand. open i can lost control of

pricing. our own country's growing output. all the bulls need is decline in oil to be more gradual or stair step so investors can reposition and cash strapped oil companies can sell properties to stay solvent. helps with two other big worries after a ruble collapse, both national oil companies have so much debt it can be crunched, and i find it a little frightening. plus, this decline stays gradual, it helps us at the point without wiping out production. finding terrific job growth in the country. sixth ingredient for a monster move. we're still getting takeovers. pantry, small convenience store chain, means night owl in french. pantry is not a sprawling outfit, mostly in the southeast. has 1500 stars and custard has

350 stores. cramer, cst brands be next? why not. speaking of winston retail, rite-aid reported earnings, five current basis. stock soared 12%. i urged you to stay in this one. we were right. i don't want you chasing it. always great when patience works and frustration is stifled with a good story. meantime, you have the ceo of kraft retiring, giving the top job to the chairman. people presume the company is for sale, about to be broken up. why not. could fetch big numbers. just the cheese whiz alone, they make the cheesesteaks at china ohs with. natural for a company like nestle to merge. and kraft to buy whitewave. go more organic. needs to. seventh ingredient for a bull cake. profits seem very strong. in part because of cheaper

gasoline. but also because business is just getting better. do you know that oracle reported a terrific number in the business, broad based. symptom jumped 10%. so did ak censure. with clients in europe. acm 5% higher. could europe be improving? you wonder after seeing a strong number from the the consultant company. darden's olive garden, it is getting there, just turned positive. you have to believe lower gas prices are playing a role. j bill, builds a lot of tech gadgets, a lot of good things happening for a lot of companies. the fact that cloud based companies roared higher?

that's darn interesting, isn't it, considering that larry ellison laid into big daddy sales force eight times in the conference call. sales force.com ran anyway. eighth ingredient you need, oh, yeah. i tell you something, i make a lot of daiquiris with this, too, big cap companies doing huge buy backs, even up here. this is much better for you than regular sugar. they're giving you higher than expected dividends and the market is lapping it up. who didn't like the huge boost from stocks, boeing and emerald. what else do we need? can't make a bull cake. biotech, market leaders bounced back. that includes sell gee, bio general ott i can. rejenner ott, jill ian, the big farm a apocalypse. this is a big deal. people are recognizing you can

never have too much butter. people recognize that these companies' prospects are terrific. we want markets to be led by growth stocks. bioteches are the epitome of growth. finally foreign markets aren't giving us trouble. emerging markets are taking a breather from a beat down. in other words, we have another -- that's what we need. i wonder how will we do it. it is all good. the recipe is working! of course, it is possible the cake can burn from overheating, perhaps i didn't mix it correctly. one of the reversals can always occur. let me give you the bottom line. it needs more egg. we are in a seasonally strong

stock market. with these ten ingredients, you have the classics for a santa claus rally, to save 2014 for the bulls. make no mistake about it, the last two days are the definition of a santa claus rally. how sweet it is. sharon from north carolina. >> caller: hello. have a question. what do you think about wynn resorts. >> if i want to be in the casino business, i believe mgm has more vegas, that's what you need, like sometimes cakes need a little more salt. can we go to gabriel in california. >> dr. cramer. thank you for empowering viewers, man, awesome work. my 23-year-old boys prefer watching you over cartoons all the time.

>> hold it, they prefer me over cartoons? the acme baking company? sure. go ahead. >> pepsi. i bought some in the early '90s, wondering if i should hedge the position. >> pepsico had a big run, i think it is renewing. the stock sold off. got raw costs coming down. i will endorse buying pepsico. i think it is a good idea. coconut profits? there are ingredients for the rally. when you mix it up, the recipe comes in just in time to save 2014, with this bull cake that i am making on "mad money" tonight. i am calling them out, helping you keep your cash secure. the biotech 10% off the ties i think you should buy now. plus, i have to tell you, i am trying to make, if you saw what i'm trying to make, you would have a better idea. i know i can do it. this is ultimately what my

product looks like. look familiar? find out how this massive cookie could change everything you think about food. i got to make two of them. yes. people say there's only one cramer. no. coming right up. stick with cramer.

there's too much hand ringing about what the fed chief wants to do. she's going to take rates higher. not with giant bond sales from huge inventory is what i prefer, but raising short term rates, but probably not until april at the earliest. critics want her to raise rates right now.

right now to raise them. here is my problem. if yellen were to raise rates, there could be serious repercussions. markets that had the biggest one day rally hang on her every word. if she raises rates, that means capital coming out of those markets in two hours. i am no fan of emerging markets funds or stocks. i was taught day one goldman, sachs 30 years ago, it is a terrible idea. you don't want risk from fixed income, you want safety or princip principal. these guys have been the skourj of the stock market for years, but she didn't trigger them. i think the timing of rate hike would be dreadful for europe. european central bank president is doing everything he can to jump start the eurozone economy, including taking on a huge amount of debt. something that angela merkel, slightly tight leader of

germany, known as herbert hoover in a pant suit seems morally opposed to it. if we tighten, it would raise the value of the dollar, but cause massive capital flight from there to here. tremendous instability when 770 million hang in the balance. the fed is supposed to raise rates when inflation rages. given that we have more deflate, we have more deflation than inflation. our economy is far from growing as a solid, sustainable pace. only now turned tail wind, thanks to plummeting price of gasoline. wasn't like that four, five months ago. business formation is strong. the affordable care act is going into full effect for business next year, that could be a real drag on small business and that's the backbone of new job creation. something else bothers me in endless complaints about yellen that you hear. tends to be from people so rich they fear purchasing power being eroded by slightest hint of inflation, can't get enough safe

income to make themselves happy, or complaints come from those short or selling short bonds and stocks. and therefore need yellen to raise rates and beat the performance bogeys. these seem to knock the fed and have done so for ages, all for naught. the stock market continues to crime and wreck performances. they would be right if we had a lot of inflation. why don't they push to adopt the plan i have of feds selling off trillions of dollars of longer term bonds they have in inventory. better balance sheet, incredible profits that would go to treasury, put a real dent in the deficit. no, no, no. these moralists fail to understand gains they could have gotten from being long bonds or stocks instead of fashionable would be acceptable at any bank. no fed induced asterisk or discount to it. believe me. most don't care about being stewards of our country's finances, no matter what they

say. they don't want what's best for the economy, they're simply trying to panic you out of owning stocks to knock them down. honestly, i find many idea logs and opportunities revolting. let me give you the bottom line. when we have inflation, then the fed which is data dependent will switch and raise rates. until then, promoting havoc, stopping the hiring binge, making it tougher for americans and europeans? is that their job, listen up, stop asking them to shore up your positions and improve performance. shut up or disclose reveal positions, including shorts and dramatically underinvested status. then take it at face value. unlike now where i see you as selfish, self promoting ministers of your own portfolio. there's much more "mad money" ahead, including a prime opportunity in biotech. find out the stock i think is ready to give you the boost you need now, and it is huge. and the race for an ebola

cure continues. i talk to a company that helped fast track it to market. plus, you know i'm all about the dough. i am wrapping my head around a company with a novel way to make it. stay with cramer. (vo) watching. waiting.

for that moment, where right place meets right time. and when i find it- i go for it. (announcer) at scottrade, we share your passion for trading. that's why we give you the edge, with innovative charting and trading features, plus powerful mobile apps so you're always connected, wherever you are. because at scottrade, our passion is to power yours.

always searching for the next big biotech stock, the next drug company to give you massive multi year gains thanks to some game changing innovation. gold standard of "mad money," the $42 billion company with a $423 stock and stable blockbuster drugs. i started to recommend it more than nine and a half years ago, it was a tiny speculative $5 stock with big dreams, but nothing in the way of products, let alone profits.

since then, they have given one of the greatest runs. up 8375%. and i think it is not done. but at this point, what gets us excited are stocks that look like they could be the next regeneron. i am circling back to isis tarp suit calls. last week we spoke to the ceo shortly after they made a groundbreaking presentation at the american society of hematology. i think they're not giving them enough credit. the stock down two bucks since that interview. that's creating an incredible entry point. isis has 34 development programs, along with a terrific platform. leaders in anti-sense technology. drugs that work by binding to rna in cells, the substance that controls expression of genes, and gives isis a brilliant,

different way to treat genetic disorders. out of everything in the pipeline, i want to talk about a single drug that's not getting enough attention. i think it is a game changer. a drug that could send this stock soaring higher than these levels all by itself. i am referring to fxi, the anti-coago lanlt isis highlighted at the meeting earlier this month. i think it is nothing short of revolutionary. this is what's known as an anti-thrombotic, it prevents blood clots. there are a lot on the market, but all have serious issues. here is the problem. while we have a number of drugs that can prevent blood clots, they tend to have unfortunate side effects, typically increased risk of bleeding or bleed out. makes sense, clotting is how the body stops itself from bleeding. you prevent clotting, there will be blood. but this is a serious problem. people need to take anticoagulants when going for surgery. the surgeon doesn't want a potentially lethal blood clot

getting into your veins. they also don't want you to bleed to death. they have to walk a fine line using the current anticoagulants. my dad that passed away last month had a stroke a couple years ago. when they did his surgery, they gave him coumadin which would cause him to bleed to death rapidly if he was alone and got hurt. the first time they used another, he had a second stroke, something they said had occurred with other patients. in short, we have a serious unmet need for a safer, more anti-coago lanlt. they made the holy grail of anticoagulants. it prevents blood clots causing much less bleeding than the competition. they released results a week and a half ago. numbers were staggering. not only did it have the lowest incidence of venus thromboembolisms, but also

resulted in lowest bleeding, too. no other drug on the market can effectively address both issues. until isis came along, not many thought it was possible. it is like science fiction. that's because it works differently. most drugs work by preventing blood clots from forming. that's why they increase risk of bleeding. isis figured out a new pathway. they inhibit an enzyme factor 11 involved. it prevents them propagating and causing real problems. this is huge, people. fxi caused no increase in spontaneous bleeding for people that only took the placebo. meaning they can prevent blood clots without the issues of other anti-coagulants. let me give you numbers so you understand how revolutionary it is. isis did a six week study of 300 patients having knee surgery.

the drug reduced vte down to 4.2%, versus 30.4% for patients that took another drug. one of the old school anti-coago lanlts. compare it to others. bristol meyers, 15%. xarelto, predaks a. isis's drugs is miles from the competition preventing dangerous blood clots. that number alone is extraordinary. it also beats them on bleeding. within the study, patients taking fqi had 2.6 incidence of bleeding versus 8.3 taking levinox. even the others have 3.5 and 3.3 incidence of bleeding. in short, isis developed a best in class drug that beats the competition on every metric. why isn't the market going wild?

why did they only jump from 52 to 56 on the news? they only studied it for knee replacement, a small market. they're looking for a broader market. now that we know their drug works better than the competition, i see no reason they shouldn't take that market by storm. we have seen that fxi is superior to some drugs. last year 2.2 billion in sales. nearly 5 billion total. a huge category. isis could take the whole $5 billion pie. and these numbers don't include untapped market of people that can't take the current generation because of risk of increased bleeding. anyone with late state kidney disease and huge set of people with ate real fibrillation. currently they're taking aspirin. 130,000 have these conditions in the united states. fxi could be the anticoagulant they could take. plus and even a broader market treating anyone with mechanical heart valves, with chronic

cardiac issues or anyone at high risk of having a stroke. i am telling you people, this could be an enormous blockbuster drug. it is not reflected in the stock. it will take time though. but eventually, it could be a $5 billion drug, if not more. that's huge, considering that isis' entire market cap is under 7 approximately. don't forget, this is just one drug. isis has a huge pipeline, three drugs in phase three that could do blockbuster level sales, but they have partners in these, they only get a piece of the pie. the anti-cholesterol drug could be worth millions, the ttrm drug, let's say maybe 250 million in royalties. bottom line on this. one of the most exciting stocks i've ever come across, isis has a lot going for it here. but the revolutionary anti-coago lanlt is the real game changer for me. stock up 47 year to date. i think you ain't seen nothing

yet. joe in massachusetts. joe. >> hi, jim, love your show. the company i'm calling about us new link genetics. i have been in it since early october. went into it for the ebola vaccine. the real story is their cancer work, pancreatic cancer and trials in late stages. where you see the company in general. >> i knew it as ebola. did i not know it as pancreatic. therefore i have to do more work. a lot of times people call me on biotech stocks and i punt. the reason is they're so fluid, i have to do more work, sir. curtis in north carolina. curtis. >> jim, great to talk to you, man. want to wish you and the crew at "mad money" merry christmas. >> that's nice. we have a great crew, even though i lost in fantasy league to one of them. go ahead. >> you're the best.

wanted to offer heart felt condolences on the loss of your pop. great american, world war ii veteran, true patriot. >> heroic. thank you very much. >> absolutely. listen, i been in the idb since around 268 mark. want to know if i should sell it, buy more gill ee add. >> that's a huge rally. you have to take some off the table. we do not want to give it back. think where we were three days ago. it had a bik move. when you get a big move, i would take a quarter off, let the rest run. what can i say, play with the right dna. isis, get to know isis. it isn't done, has years of vitality ahead. much more "mad money" ahead. a company testing the top 100 drugs from 2013. i put its stock under the microscope. then i can't believe it is not mayo. the healthy alternative that got the entire food chain in an

uproar. and your calls next on the lightning round. stick with cramer. [coughing]

dave, i'm sorry to interrupt... i gotta take a sick day tomorrow. dads don't take sick days, dads take nyquil. the nighttime, sniffling, sneezing, coughing, aching, fever, best sleep with a cold, medicine.

fabulous day for the bulls like this one, always worth asking what stocks will still

work, even if all our worst fears about russia, brazil, mexico, and domestic companies come true. the drug business won't be effected. that's why tonight i want to look at quinn tiles. letter q. i describe it as arms dealer to the pharmaceutical industry. major focus on late stage clinical trials. whereby oh tech firms spend most of the money to bring the most promising drug candidates to market. it is the largest contract research organization out there. call them cros. with big farm a outsourcing research and development, it stands to benefit enormously. if you want a drug approved, go to quinn tiles for clean data, accuracy and speed the fda wants to see. they reported end of october and delivered strong results. in line revenues up 13.8%, $10.75 billion backlog. that means they have way more

business than they can handle. ultra high quality problem. they'll work that out. private equity shareholder, sold at 58.20. the company bought back 4.3 million of the shares. highly unusual. since then, stocks have bounced between 56 and 58. broke out over 59 today. could be more up side. give us 17% gain since end of may. let's check with tom pike, ceo, to hear more about how his company is doing and where it is headed. welcome back to "mad money." >> hi, jim, great to be with you. >> first, i go to your website. what does it say, it says improve your probability of success. that's the theme. how can i improve my probability of success versus the other guys. aren't you all just doing tests. >> well, you know, we are about

improving our customers' probability of success. what happened there, our executives got together, looked at branding, we said to ourselves what do we really want to help our customers with. what can we do for them. what would be a statement that really focuses our organization on our customers. and we decided we should focus on their probability of success. if you think about a drug, the real key is it should fail fast, if it is not safe or efficacious, but we should move fast if it is safe and does work well. so what we want to do is increase that probability of success that our customers develop in commercialized drugs effectively. >> we talked earlier about ebola, we understood that quinntiles threw in some of the studies. are we further along than we were three months ago? are there things going on, not everything is public, where you are surprised that we're coming

so close on ebola. >> well, i think we're pleased with the progress. if you look at what's happening in the trials, we've got some situations like announcement that gsk drug is having response in patients and has reasonable safety associated with it. in addition, we're starting to look at some various ways to use plasma, folks that survived ebola to figure out if that can be used in a larger treatment setting. >> and that's you that does that? >> well, what we do is we help them test. we work with companies to help them test, make sure the drugs are safe and work. we are doing work around ebola trials. >> on your conference call you said the overall market is unchanged, no meaningful lift, but complexity is helping you and you're taking share. aren't more and more drugs being developed all the time and we need more testing? >> that's right. there are over 10,000 drugs incident pipelines in various stages, and basically what we've

got to do, we've got such great targeted therapies, such a burden of disease in the country and around the world that we've got to make sure the drugs are safe, and make sure they work. for us right now, as we look out over the next two or three years, we see tremendous continued opportunity around helping with drug development, drug commercialization. >> i was surprised to see you have helped develop or commercialize all, not some, but all of 2013's top 100 best selling drugs on the market. what kind of share did you have when you first came public versus what you have now. that's a pretty impressive number. >> well, we have grown, so i think you talked about our numbers this year. we've got about 13.8% growth in the quarter and our backlog is large at 10.75 billion. we have actually added more to backlog, jim, than all other public competitors combined this year. >> i got to tell you, that's impressive. that's why we were, right when you came public, everyone wanted all of the hot deals.

i said go with q. i remember after 2000, so many companies went under, you guys just did better and better and better. thank you, tom pike. ceo of quintiles. good to see you. >> thank you very much. >> they do a better job, every time it pulled back. we pound the table on it, we will keep doing so. "mad money" back after the break. you thought this ten pound cookie dough replica of cramer's dome was shopping, find out why the missing ingredient from this recipe could disrupt a whole industry, just ahead.

it is time for the lightning round. when you hear the buzzer the lightning round is over. brian in tennessee. brian. >> hey, jim. big southern boo-yah from nashville, tennessee.

how you doing. >> doing well, how about you, brian? >> pretty good. am i too late to get into starbucks? >> wait for pull back. lighten up a little bit. huge position. come back a little. been a little doggy. all right. let's go to john in pennsylvania. john. >> mr. cramer. >> yes. >> i never got my question finished last week. what are the m and a rumors surrounding kbr. >> i don't know, infrastructure business is challenged by the fact oil and gas came down so much. the stock is cheap. i prefer floor. flr. henry in new york. >> yes. cramer? >> yeah. >> how are you? how you doing? >> doing pretty good, how about you? >> okay, fine, thank you. i'm sorry about your father. i give my condolences to you and

your family. >> thank you, man. >> you have my regards. now mr. cramer is the first time i call you. you be very helpful to me. this is my question. i purchase about three days or four days, i purchase macy's. >> i like macy's. did shopping there this weekend. here's the problem with macy's. had a big run as many retailers had. i still think it can be higher. gasoline keeps coming down, that's key. james in connecticut. james. >> hello, jim, how are you? >> fine, james, how about you. >> thank you. i'm great. i wanted to say one thing. thank you very much for your program on savings. i think it is very important for young people. >> got to do more of them. that's exactly what we'll do. all right. let's talk stocks. >> hopefully you'll do that again. >> we will. >> my question is about

transocean. >> it is going to be okay, can bounce. i have seen the number of ships coming on, day rates are plummeting, the balance sheet is a little challenged. travel trust owns esv, it is a disaster but better than rig. pat in delaware. >> yes, hi. >> hi. >> i'd like to know what you think of hsbc holding. >> no, i would rather be in jpmorgan. big international bank, you want to be in jpmorgan. that's the conclusion of the lightning round. >> the lightning round, sponsored by td ameritrade.

tonight we are getting in on the boom of healthy foods. that future may look like hampton creek foods, maker of plant based egg free alternatives for mayonnaise and cookie dough. two products, just mayo and cookies, are healthier and cheaper than egg based competition. finally give vegans a way to fill that mayonnaise flavored hole in their stomachs. their products are available in the u.s. and asia, everybody from whole foods, kroger, costco, walmart. incredible given you couldn't find it anywhere a year ago.

today the company announced it raised $90 million in financing, which it is going to invest in r&d and accelerate expansion in western europe and asia. any major packaged food planners should be desperate to get this company. private held companies that are revolutionizing their industries. i checked in with the founder of hampton creek foods and man who has proven that you can make an omelet without breaking any eggs. take a look. josh, just mayo does a lot of things. and it is famous for being already in whole foods, a lot of big stores really like it. start with the elephant in the room. that's me. how is that possible? >> that's a cookie dough head, jim. that if you want to, you can actually eat. one of our film makers's girlfriend is a sculptor. thought it might be good if we

take the product, cookie dough, shab it into what we hope is uncanny resemblance of your pet. >> it is something i hadn't thought would be used. i want to talk about the notion of health and this. if you leave mayo out, you could get salmonella. that's not the case with this kind of mayo. >> you got it. it is not the case. we tried to put together something healthier, safer. and more affordable. and we put it together. this is in walmart, whole foods, safe way, all over the place. that's really what hampton creek is about. that's our philosophy. >> even since i saw you last, seems like everyone decided they have to offer this kind of product. >> they have. we don't look at it as a trend, jim, we look at it in order to create a world in which 99% of the food isn't that bad for the body or planet, you have to create a world where good food that's better for the body and planet is more affordable,

tastes better. otherwise, change is a fantasy. >> how can this have the same texture and feel. >> we have a team of data scientists, bio chemists, some led google and other teams. 4,000 plant species haven't been searched through. we find the best of them, use it instead of chicken egg. >> sometimes i don't like butter, too fattening. i can get i can't believe it is not butter, which is a product from, nileefr. >> they filed a lawsuit against us fairly recently. not to say before i get into details. i think it is a good company with good people. their heart is in the right place, as a company going in the right direction. >> isn't it an identity crisis? their fresh mayo and your fresh mayo. they're claiming the fda said only this is mayo. and you can't use mayo. >> i think for us, part of the

reason this lawsuit strikes a deep chord with us, our philosophy as a company, they invested in us. >> last round. >> the reason is we believe good things should be more affordable. we didn't want just mayo to be a nice alternative substitute product, we wanted it to be the only thing. >> i have been a backer of white way, a winner. the ceo told me over and over that plant based milk, not real, generic term, is going to be huge in china because of the food chain and how corrupt it is. how big can this be in china. >> today we're selling just mayo in the largest grocery store in hong kong. one of the investors, someone we're proud to be connected with, i think it can be billing and i think it can be big because the population is exploding. the only way you feed people in a way that works is if you make

the good thing more affordable and safer. part of this round of funding is going to pretty intense expansion across china and elsewhere in asia. >> we only have white wave. it is not organic. we only have white wave and hane the only two. boulder i am not counting. this is a different company. if you came public, it could be huge. we need another national organic. what are you waiting for. >> i have to say, jim, i don't see hampton creek as natural and organic space. right? my dad, i like white wave and hane. my dad isn't going to walmart, kroger, safe way, costco and doing that. he is buying the cheapest, most affordable. the thing he had his entire life. we want to go after people like my dad, the mainstream. that's our point of view, that's the point of view we're taking, for us, we had a few companies offer to acquire us. that's not our path.

that's not our path. >> to me, the fact that we used to use margerine growing up, butter was too expensive. never knew the difference. probably tasted better. this probably tastes better. >> it tastes better. costco, even a big food service company said i believe in these cookies, i believe in the philosophy. we're ready to run. >> i believe in it, too. you can't buy shares in it yet. and it is being sued. i can't believe it is not mayo! stay with cramer.

i want you to remember, three days ago people were desperate. all you heard was sell, sell, sell. i told you keep your head calm. okay? that's what you have to do. big number after the bell, could have another rally tomorrow. find it here on "mad money." i am jim cramer. see you tomorrow.

>> narrator: in this episode of "american greed," fen-phen, the miracle weight-loss drug of the '90s, turns out to have a serious side effect. >> for some of these patients, this was very scary. this was a death sentence for some of them. >> narrator: when the story breaks, ambulance-chasing lawyers rush in, exploit tragedy, and pilfer their clients' money. >> these lawyers were already going to legally be paid fees in the amount of $60 million, but that wasn't enough. so they took $126 million out of a $200 million settlement. >> they wanted their rollses. they wanted their planes. they wanted their horses. they wanted it all.